HBV cure: what is coming in 5 – 10 years? | Patrick Kennedy, MD

International Workshop on HIV & Hepatitis Co-infection 2017

EASL highlights 2017 | Jürgen Rockstroh, MD

International Workshop on HIV & Hepatitis Co-infection 2017

Management of end-stage liver disease in HIV patients | Ana Morbey, MD

International Workshop on HIV & Hepatitis Co-infection 2017

News on hepatitis delta and HIV infections | Vincent Soriano, MD, PhD

International Workshop on HIV & Hepatitis Co-infection 2017

Hepatitis E in HIV | Kenneth Sherman, MD, PhD

International Workshop on HIV & Hepatitis Co-infection 2017

Management of HCV in intravenous drug users: special considerations | Rui Sarmento e Castro, MD, PhD

International Workshop on HIV & Hepatitis Co-infection 2017

Value-based healthcare in HIV management – The Patienst’ Perspective - real life | Kees Brinkman, MD, PhD

European Workshop on Healthy Living with HIV 2017

Value-based healthcare in HIV management – The Clinicians’ Perspective | Jean-Jacques Parienti

European Workshop on Healthy Living with HIV 2017

Value-based healthcare in HIV management – The Economists Perspective | Phil McEwan

European Workshop on Healthy Living with HIV 2017

Case discussion: Demonstrative cases of social media based HIV and medical non-HIV programs in the community | Guido van den Berk, MD, PhD

European Workshop on Healthy Living with HIV 2017

The role of social media in optimizing medical care | Matthew Hodson

European Workshop on Healthy Living with HIV 2017

Case discussion: How do drugs/patients impact need and type of monitoring | Marta Boffito, MD, PhD, FRCP

European Workshop on Healthy Living with HIV 2017

Case discussion: How do drugs/patients impact need and type of monitoring | Laura Waters, MD, FRCP

European Workshop on Healthy Living with HIV 2017

The future of patient monitoring | Hans-Jürgen Stellbrink, MD

European Workshop on Healthy Living with HIV 2017

Case discussion: Co-morbidities in people living with HIV | Roger Paredes, MD, PhD

European Workshop on Healthy Living with HIV 2017

Optimizing antiretroviral drugs for the Aging patient | Giovanni Guaraldi, MD

European Workshop on Healthy Living with HIV 2017

The impact of antiretroviral drugs on cardiovascular health | Jose Lopez-Sendon

European Workshop on Healthy Living with HIV 2017

The impact of antiretroviral drugs on renal function | Bruce Hendry, BM, BCh, MD, PhD

European Workshop on Healthy Living with HIV 2017

HIV Macroprevention; epidemiology, phylogenic and networks | Charles Boucher, MD, PhD

European Workshop on Healthy Living with HIV 2017

HIV cure and eradication | Ricardo Diaz, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

Present and future of ART in Latin America | Carlos Beltrán, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

Do we really need new drugs? | Mark Nelson, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

The aging HIV infected patient - neurological issues - poly pharmacy | Ernesto Martinez Buitrago, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Women - PTMCT - pregnancy | Isabel Cassetti, MD

Andean Pacific Workshop on HIV & Hepatitis 2017